Cart
sales@molnova.com
PRI-724 B
CAS No. 1422253-38-0
PRI-724 B( —— )
Catalog No. M35828 CAS No. 1422253-38-0
PRI-724 is a second-generation, selective small molecule inhibitor of the β-catenin/CBP interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 64 | Get Quote |
|
| 5MG | 93 | Get Quote |
|
| 10MG | 148 | Get Quote |
|
| 25MG | 256 | Get Quote |
|
| 50MG | 410 | Get Quote |
|
| 100MG | 596 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePRI-724 B
-
NoteResearch use only, not for human use.
-
Brief DescriptionPRI-724 is a second-generation, selective small molecule inhibitor of the β-catenin/CBP interaction.
-
DescriptionPRI-724 is a second-generation, selective small molecule inhibitor of the β-catenin/CBP interaction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1422253-38-0
-
Formula Weight658.64
-
Molecular FormulaC33H35N6O7P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@@H]1N2[C@@](N(C(NCC3=CC=CC=C3)=O)N(C)CC2=O)([C@H](C)N(CC=4C5=C(C=CC4)C=CC=N5)C1=O)[H])C6=CC=C(OP(=O)(O)O)C=C6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
WWL70
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM). WWL70 (10 μM, 1 h) treatment, 2-Arachidonoylglycerol is increased by 20% compared to untreated cells.
-
K-756
K-756 is a direct and selective inhibitor of tankyrase (TNKS), which inhibits the ADP-ribosylation activity of TNKS1 (IC50 = 31 nM) and TNKS2 (IC50 = 36 nM).
-
Vantictumab
Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
